Journal of Dentistry-Shiraz University of Medical Sciences. 2009; 9 (Supp.): 31-34
en Inglés
| IMEMR
| ID: emr-91719
ABSTRACT
Psychosocial factors are thought to play a role in burning mouth syndrome [BMS] and several therapeutic approaches for BMS are based on this consideration. This paper evaluated the efficacyof the combined systemic administration of citalopram and clonazepam, as anti-depressant and anti-anxiety drugs, in the management of burning mouth syndrome and reduction of the burning sensation. In this cross-sectional study, 80 subjects suffering from idiopathic burning mouth syndrome were enrolled. The patients underwent a thorough clinical examination. Oral symptoms before and after treatment were assessed using a Visual Analogue Scale. The mean duration of burning in our patients was 7 months. Systemic combination of citalopram [20mg/daily] and clonazpam [0.25 mg/daily] was prescribed for all of them for 8 weeks. Then, the data were analysed, using Student's t-test. Of the 62 patients who completed the protocol, 38 reported complete remission of the oral burning sensation. However, 20 patients reported a little improvement, and four of them reported no improvement. These data suggest that citaloperam with colonazpam is effective in patients with BMS
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Ansiolíticos
/
Dimensión del Dolor
/
Citalopram
/
Estudios Transversales
/
Clonazepam
/
Manejo de la Enfermedad
/
Antidepresivos
Tipo de estudio:
Estudio de prevalencia
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
J. Dent.-Shiraz Univ. Med. Sci.
Año:
2009
Similares
MEDLINE
...
LILACS
LIS